Brief: CymaBay Reports Third Quarter And Nine Months Ended Sept 30 Financial Results

CymaBay Therapeutics

14/11/2022 21:43

Nov 14 (Reuters) - Cymabay Therapeutics Inc  CBAY.O :
    * CYMABAY REPORTS THIRD QUARTER AND NINE MONTHS ENDED
SEPTEMBER
30, 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * QTRLY LOSS PER SHARE $0.28
    * HELD $153.4 MILLION IN CASH, CASH EQUIVALENTS AND
INVESTMENTS AS
OF SEPTEMBER 30, 2022
    * CASH AND INVESTMENTS ON HAND ARE SUFFICIENT TO FUND
CYMABAY'S
OPERATING PLAN THROUGH 2023
    * Q3 EARNINGS PER SHARE VIEW $-0.30 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7PM571 
Further company coverage:  CBAY.O 
 ((Reuters.Briefs@thomsonreuters.com;))